ARTICLE | Company News
Forest Laboratories sales and marketing update
January 17, 2005 8:00 AM UTC
FRX launched its Campral acamprosate delayed-released tablets to treat alcohol dependence in patients who are abstinent from alcohol at treatment initiation. Campral is partnered with Merck KGaA (FSE...